
Heart failure induced by cancer therapies: focus on targeted agents, mechanisms, risk prediction, and clinical management
<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxNQzdOdDVKWlpZdTYzSTRIekViVDcycFotaE1odEtxcFFXcXRUMlBwQmlLTXdzLVM2TmNpbDFMTEN0R2VCSG5JT0o1N094MEZBU3pqazdFOWp5Zlo0bE1JR21Fakh0bWRMT2hLYmRORjZadjRyUEhPSHN4UUlXUEZIbjF3bUZIZGpEaHh4Tl9HU0o2Mmln?oc=5" target="_blank">Heart failure induced by cancer therapies: focus on targeted agents, mechanisms, risk prediction, and clinical management</a>&nbsp;&nbsp;<font color="#6f6f6f">Frontiers</font>
